Pylori Infection and Colon Cancer J Clin Med Res • 2012;4(3):172-176 Shulkes A, Baldwin GS. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology. 1997;113(5):1576-1588. 14. Hoosein NM, Kiener PA, Curry RC, Brattain MG. Evi- dence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res. 1990;186(1):15-21. 15. Chao C, Hellmich MR. Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):33-39. 16. Aly A, Shulkes A, Baldwin GS. Gastrins, cholecystoki- nins and gastrointestinal cancer. Biochim Biophys Acta. 2004;1704(1):1-10. 17. Bertrand C, Kowalski-Chauvel A, Do C, Resa C, Najib S, Daulhac L, Wang TC, et al. A gastrin precursor, gas- trin-gly, upregulates VEGF expression in colonic epithe- lial cells through an HIF-1-independent mechanism. Int J Cancer. 2010;126(12):2847-2857. 18. Kameyama M, Fukuda I, Imaoka S, Nakamori S, Iwa- naga T. Level of serum gastrin as a predictor of liver metastasis from colorectal cancer. Dis Colon Rectum. 1993;36(5):497-500. 19. Kameyama M, Nakamori S, Imaoka S, Yasuda T, Na- kano H, Ohigashi H, Hiratsuka M, et al. [Adjuvant chemo-endocrine chemotherapy with gastrin antagonist after resection of liver metastasis in colorectal cancer]. Gan To Kagaku Ryoho. 1994;21(13):2169-2171. 20. Smith JP, Wood JG, Solomon TE. Elevated gastrin lev- els in patients with colon cancer or adenomatous polyps. Dig Dis Sci. 1989;34(2):171-174. 21. Upp JR, Jr., Singh P, Townsend CM, Jr., Thompson JC. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989;49(2):488-492. 22. Wong K, Beardshall K, Waters CM, Calam J, Poston GJ. Postprandial hypergastrinaemia in patients with colorec- tal cancer. Gut. 1991;32(11):1352-1354. 23. Fontanesi BV, Boris B, Delcio M, Manoukian FN. Gas- trin levels in patients with colorectal cancer. Hepatogas- troenterology. 1997;44(16):1082-1084. 24. Vanderstraeten EF, De Vos MM, Versieck JM, Elewaut AP. Serum gastrin levels and colorectal neoplasia. Dis Colon Rectum. 1995;38(2):172-176. 25. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, et al. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epi- demiol Biomarkers Prev. 2002;11(10 Pt 1):1095-1099. 26. Kim JH, Park HJ, Cho JS, Lee KS, Lee SI, Park IS, Kim CK. Relationship of CagA to serum gastrin concentra- tions and antral G, D cell densities in Helicobacter pylori infection. Yonsei Med J. 1999;40(4):301-306. 27. Peek RM, Jr., Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflamma- tory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995;73(6):760- 770. 28. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-anal- ysis of different test indicators: Helicobacter pylori in- fection and the risk of colorectal cancer. Int J Colorectal Dis. 2008;23(9):875-882. 29. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, et al. Atrophic gas- tritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter. 2007;12(4):328-332. 30. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gas- troenterol. 2001;96(1):84-88. 31. Aydin A, Karasu Z, Zeytinoglu A, Kumanlioglu K, Ozacar T. Colorectal adenomateous polyps and He- licobacter pylori infection. Am J Gastroenterol. 1999;94(4):1121-1122. 32. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995;87(10):762-763. 33. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorec- tal cancer: a prospective study. Gastroenterology. 1998;115(2):275-280. 34. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, et al. High prevalence of Helico- bacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol. 1997;25(4):605- 607. 35. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, et al. Heli- cobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis. 2001;16(4):202-210. 36. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Lei- endecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999;60(3):210-215. 37. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastro- enterol. 2001;96(12):3406-3410. 176 Articles © The authors | Journal compilation © J Clin Med Res and Elmer Press™ | www.jocmr.org